Well-Differentiated Liver Cancers Reveal the Potential Link between ACE2 Dysfunction and Metabolic Breakdown

Researchers analyzed angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 expression and localization in human liver cancers and in non-tumor livers.